Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-76fb5796d-25wd4 Total loading time: 0 Render date: 2024-04-27T07:10:15.074Z Has data issue: false hasContentIssue false

Chapter 48 - Malignant Disease in Pregnancy (Content last reviewed: 15th October 2018)

from Section 5 - Late Pregnancy – Maternal Problems

Published online by Cambridge University Press:  15 November 2017

By
Rabbie K. Hanna  and
Adnan R. Munkarah
Edited by
David James ,
Philip Steer ,
Carl Weiner ,
Bernard Gonik  and
Stephen Robson
David James
Affiliation:
University of Nottingham
Philip Steer
Affiliation:
Imperial College London
Carl Weiner
Affiliation:
University of Kansas
Bernard Gonik
Affiliation:
Wayne State University, Detroit
Stephen Robson
Affiliation:
University of Newcastle
Get access

Summary

The probability of developing malignancy in females under 50 years of age is estimated to be 1 in 18; about 5200 females under 40 years of age died of cancer in 2014 in the US, making it the second leading cause of death in women younger than 40 years, and fortunately, a rare cause of maternal mortality.

Type
Chapter
Information
High-Risk Pregnancy
Management Options
 , pp. 1427 - 1443
Publisher: Cambridge University Press
First published in: 2017

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Further Reading

Amant, F, Deckers, S, Van Calsteren, K, et al. Breast cancer in pregnancy: recommendations of an international consensus meeting. Eur J Cancer 2010; 46: 3158–68.Google Scholar
Amant, F, Halaska, MJ, Fumagalli, M, et al. Gynecologic cancers in pregnancy: guidelines of a second international consensus meeting. Int J Gynecol Cancer 2014; 24: 394–403.Google Scholar
Azim, HA, Pavlidis, N, Peccatori, FA. Treatment of the pregnant mother with cancer: a systematic review on the use of cytotoxic, endocrine, targeted agents and immunotherapy during pregnancy. Part II: Hematological tumors. Cancer Treat Rev 2010; 36: 110–21.Google Scholar
Azim, HA, Peccatori, FA, Pavlidis, N. Treatment of the pregnant mother with cancer: a systematic review on the use of cytotoxic, endocrine, targeted agents and immunotherapy during pregnancy. Part I: Solid tumors. Cancer Treat Rev 2010; 36: 101–9.Google Scholar
Brenner, B, Avivi, I, Lishner, M. Haematological cancers in pregnancy. Lancet. 2012; 379: 580–7.Google Scholar
Cardonick, E. Pregnancy-associated breast cancer: optimal treatment options. Int J Womens Health 2014; 6: 935–43.Google ScholarPubMed
Peccatori, FA, Azim, HA, Orecchia, R, et al. Cancer, pregnancy and fertility: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2013; 24 (Suppl 6): vi160–70.CrossRefGoogle ScholarPubMed
Salani, R, Billingsley, CC, Crafton, SM. Cancer and pregnancy: an overview for obstetricians and gynecologists. Am J Obstet Gynecol 2014; 211: 7–14.Google Scholar
Selig, BP, Furr, JR, Huey, RW, et al. Cancer chemotherapeutic agents as human teratogens. Birth Defects Res A Clin Mol Teratol 2012; 94: 626–50.CrossRefGoogle ScholarPubMed

References

Siegel, RL, Miller, KD, Jemal, A. Cancer statistics, 2017. CA Cancer J Clin 2017; 67: 7–30.CrossRefGoogle ScholarPubMed
Peccatori, FA, Azim, HA, Orecchia, R, et al. Cancer, pregnancy and fertility: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 2013; 24 (Suppl 6): vi160–70.Google Scholar
Miniño, AM. Death in the United States, 2011. NCHS Data Brief 2013; (115): 1–8.Google Scholar
Cardonick, E. Pregnancy-associated breast cancer: optimal treatment options. Int J Womens Health 2014; 6: 935–43.Google Scholar
Salani, R, Billingsley, CC, Crafton, SM. Cancer and pregnancy: an overview for obstetricians and gynecologists. Am J Obstet Gynecol 2014; 211: 7–14.CrossRefGoogle ScholarPubMed
Stensheim, H, Moller, B, van Dijk, T, Fossa, SD. Cause-specific survival for women diagnosed with cancer during pregnancy or lactation: a registry-based cohort study. J Clin Oncol 2009; 27: 45–51.Google Scholar
Ahn, BY, Kim, HH, Moon, WK, et al. Pregnancy- and lactation-associated breast cancer: mammographic and sonographic findings. J Ultrasound Med 2003; 22: 491–7.Google Scholar
Brenner, B, Avivi, I, Lishner, M. Haematological cancers in pregnancy. Lancet. 2012; 379: 580–7.CrossRefGoogle ScholarPubMed
Han, SN, Verheecke, M, Vandenbroucke, T, et al. Management of gynecological cancers during pregnancy. Curr Oncol Rep 2014; 16: 415.Google Scholar
Leiserowitz, GS, Xing, G, Cress, R, et al. Adnexal masses in pregnancy: how often are they malignant? Gynecol Oncol 2006; 101: 315–21.Google Scholar
Morice, P, Uzan, C, Gouy, S, Verschraegen, C, Haie-Meder, C. Gynaecological cancers in pregnancy. Lancet 2012; 379: 558–69.Google Scholar
Smith, LH, Danielsen, B, Allen, ME, Cress, R. Cancer associated with obstetric delivery: results of linkage with the California cancer registry. Am J Obstet Gynecol 2003; 189: 1128–35.CrossRefGoogle ScholarPubMed
American College of Obstetricians and Gynecologists. ACOG Committee Opinion. Number 299, September 2004 (replaces No. 158, September 1995). Guidelines for diagnostic imaging during pregnancy. Obstet Gynecol 2004; 104: 647–51.Google Scholar
Wang, PI, Chong, ST, Kielar, AZ, et al. Imaging of pregnant and lactating patients: part 1, evidence-based review and recommendations. AJR Am J Roentgenol 2012; 198: 778–84.Google Scholar
Donnelly, EH, Smith, JM, Farfan, EB, Ozcan, I. Prenatal radiation exposure: background material for counseling pregnant patients following exposure to radiation. Disaster Med Public Health Prep 2011; 5: 62–8.CrossRefGoogle ScholarPubMed
Amant, F, Deckers, S, Van Calsteren, K, et al. Breast cancer in pregnancy: recommendations of an international consensus meeting. Eur J Cancer 2010; 46: 3158–68.CrossRefGoogle ScholarPubMed
Shellock, FG, Kanal, E. Safety of magnetic resonance imaging contrast agents. J Magn Reson Imaging 1999; 10: 477–84.Google Scholar
Vashi, R, Hooley, R, Butler, R, Geisel, J, Philpotts, L. Breast imaging of the pregnant and lactating patient: imaging modalities and pregnancy-associated breast cancer. AJR Am J Roentgenol 2013; 200: 321–8.Google Scholar
Morice, P, Narducci, F, Mathevet, P, et al. French recommendations on the management of invasive cervical cancer during pregnancy. Int J Gynecol Cancer 2009; 19: 1638–41.CrossRefGoogle ScholarPubMed
Zanotti-Fregonara, P. Pregnancy should not rule out 18FDG PET/CT for women with cancer. Lancet 2012; 379: 1948.Google Scholar
Amant, F, Halaska, MJ, Fumagalli, M, et al. Gynecologic cancers in pregnancy: guidelines of a second international consensus meeting. Int J Gynecol Cancer 2014; 24: 394–403.Google Scholar
Selig, BP, Furr, JR, Huey, RW, et al. Cancer chemotherapeutic agents as human teratogens. Birth Defects Res A Clin Mol Teratol 2012; 94: 626–50.Google Scholar
Dale, DC, Cottle, TE, Fier, CJ, et al. Severe chronic neutropenia: treatment and follow-up of patients in the Severe Chronic Neutropenia International Registry. Am J Hematol 2003; 72: 82–93.Google Scholar
Azim, HA, Pavlidis, N, Peccatori, FA. Treatment of the pregnant mother with cancer: a systematic review on the use of cytotoxic, endocrine, targeted agents and immunotherapy during pregnancy. Part II: Hematological tumors. Cancer Treat Rev 2010; 36: 110–21.Google Scholar
Cardonick, E, Iacobucci, A. Use of chemotherapy during human pregnancy. Lancet Oncol 2004; 5: 283–91.Google Scholar
Pagani, O, Partridge, A, Korde, L, et al. Pregnancy after breast cancer: if you wish, ma’am. Breast Cancer Res Treat 2011; 129: 309–17.Google Scholar
Azim, HA, Peccatori, FA, Pavlidis, N. Treatment of the pregnant mother with cancer: a systematic review on the use of cytotoxic, endocrine, targeted agents and immunotherapy during pregnancy. Part I: Solid tumors. Cancer Treat Rev 2010; 36: 101–9.Google Scholar
Falk, AT, Barriere, J, Francois, E, Follana, P. Bevacizumab: a dose review. Crit Rev Oncol Hematol 2015; 94: 311–22.CrossRefGoogle ScholarPubMed
Toesca, A, Gentilini, O, Peccatori, F, Azim, HA, Amant, F. Locoregional treatment of breast cancer during pregnancy. Gynecol Surg 2014; 11: 279–84.Google Scholar
DeSantis, CE, Lin, CC, Mariotto, AB, et al. Cancer treatment and survivorship statistics, 2014. CA Cancer J Clin 2014; 64: 252–71.Google Scholar
Pereg, D, Koren, G, Lishner, M. Cancer in pregnancy: gaps, challenges and solutions. Cancer Treat Rev 2008; 34: 302–12.Google Scholar
Nettleton, J, Long, J, Kuban, D, et al. Breast cancer during pregnancy: quantifying the risk of treatment delay. Obstet Gynecol 1996; 87: 414–18.Google Scholar
Petrek, JA. Breast cancer and pregnancy. J Natl Cancer Inst Monogr 1994; (16): 113–21.Google Scholar
Clark, RM, Chua, T. Breast cancer and pregnancy: the ultimate challenge. Clin Oncol (R Coll Radiol) 1989; 1: 11–18.Google Scholar
Rodriguez, AO, Chew, H, Cress, R, et al. Evidence of poorer survival in pregnancy-associated breast cancer. Obstet Gynecol 2008; 112: 71–8.CrossRefGoogle ScholarPubMed
Amant, F, von Minckwitz, G, Han, SN, et al. Prognosis of women with primary breast cancer diagnosed during pregnancy: results from an international collaborative study. J Clin Oncol 2013; 31: 2532–9.Google Scholar
Azim, HA, Santoro, L, Russell-Edu, W, et al. Prognosis of pregnancy-associated breast cancer: a meta-analysis of 30 studies. Cancer Treat Rev 2012; 38: 834–42.Google Scholar
Loibl, S, von Minckwitz, G, Gwyn, K, et al. Breast carcinoma during pregnancy. International recommendations from an expert meeting. Cancer 2006; 106: 237–46.Google Scholar
Berry, DL, Theriault, RL, Holmes, FA, et al. Management of breast cancer during pregnancy using a standardized protocol. J Clin Oncol 1999; 17: 855–61.Google Scholar
Rosenkranz, KM, Lucci, A. Surgical treatment of pregnancy associated breast cancer. Breast Dis 2005; 23: 87–93.Google Scholar
Gropper, AB, Calvillo, KZ, Dominici, L, et al. Sentinel lymph node biopsy in pregnant women with breast cancer. Ann Surg Oncol 2014; 21: 2506–11.Google Scholar
Khera, SY, Kiluk, JV, Hasson, DM, et al. Pregnancy-associated breast cancer patients can safely undergo lymphatic mapping. Breast J 2008; 14: 250–4.Google Scholar
Upponi, SS, Ahmad, F, Whitaker, IS, Purushotham, AD. Pregnancy after breast cancer. Eur J Cancer 2003; 39: 736–41.Google Scholar
Velentgas, P, Daling, JR, Malone, KE, et al. Pregnancy after breast carcinoma: outcomes and influence on mortality. Cancer 1999; 85: 2424–32.Google Scholar
Eedarapalli, P, Biswas, N, Coleman, M. Epirubicin for breast cancer during pregnancy: a case report. J Reprod Med 2007; 52: 730–2.Google Scholar
Gadducci, A, Cosio, S, Fanucchi, A, et al. Chemotherapy with epirubicin and paclitaxel for breast cancer during pregnancy: case report and review of the literature. Anticancer Res 2003; 23: 5225–9.Google Scholar
Mendez, LE, Mueller, A, Salom, E, Gonzalez-Quintero, VH. Paclitaxel and carboplatin chemotherapy administered during pregnancy for advanced epithelial ovarian cancer. Obstet Gynecol 2003; 102: 1200–2.Google Scholar
Sood, AK, Shahin, MS, Sorosky, JI. Paclitaxel and platinum chemotherapy for ovarian carcinoma during pregnancy. Gynecol Oncol 2001; 83: 599–600.CrossRefGoogle ScholarPubMed
Dawrant, MJ, Giles, S, Bannigan, J, Puri, P. Adriamycin produces a reproducible teratogenic model of vertebral, anal, cardiovascular, tracheal, esophageal, renal, and limb anomalies in the mouse. J Pediatr Surg 2007; 42: 1652–8.Google Scholar
Dawrant, MJ, Giles, S, Bannigan, J, Puri, P. Adriamycin produces a reproducible teratogenic model of gastrointestinal atresia in the mouse. Pediatr Surg Int 2008; 24: 731–5.Google Scholar
Kim, JH, Kim, HS, Sung, CW, et al. Docetaxel, gemcitabine, and cisplatin administered for non-small cell lung cancer during the first and second trimester of an unrecognized pregnancy. Lung Cancer 2008; 59: 270–3.Google Scholar
Mir, O, Berveiller, P, Ropert, S, et al. Emerging therapeutic options for breast cancer chemotherapy during pregnancy. Ann Oncol 2008; 19: 607–13.Google Scholar
Gonzalez-Angulo, AM, Broglio, K, Kau, SW, et al. Women age ≤ 35 years with primary breast carcinoma: disease features at presentation. Cancer 2005; 103: 2466–72.Google Scholar
Witzel, ID, Muller, V, Harps, E, Janicke, F, Dewit, M. Trastuzumab in pregnancy associated with poor fetal outcome. Ann Oncol 2008; 19: 191–2.Google Scholar
Zagouri, F, Sergentanis, TN, Chrysikos, D, et al. Trastuzumab administration during pregnancy: a systematic review and meta-analysis. Breast Cancer Res Treat 2013; 137: 349–57.Google Scholar
Kelly, H, Graham, M, Humes, E, et al. Delivery of a healthy baby after first-trimester maternal exposure to lapatinib. Clin Breast Cancer 2006; 7: 339–41.Google Scholar
Gerardin, DC, Pereira, OC. Reproductive changes in male rats treated perinatally with an aromatase inhibitor. Pharmacol Biochem Behav 2002; 71: 301–5.Google Scholar
Kragie, L. Aromatase in primate pregnancy: a review. Endocr Res 2002; 28: 121–8.Google Scholar
Sankila, R, Heinavaara, S, Hakulinen, T. Survival of breast cancer patients after subsequent term pregnancy: “healthy mother effect”. Am J Obstet Gynecol 1994; 170: 818–23.Google Scholar
Ives, A, Saunders, C, Bulsara, M, Semmens, J. Pregnancy after breast cancer: population based study. BMJ 2007; 334: 194.Google Scholar
Sood, AK, Sorosky, JI. Invasive cervical cancer complicating pregnancy. How to manage the dilemma. Obstet Gynecol Clin North Am 1998; 25: 343–52.Google Scholar
Zagouri, F, Sergentanis, TN, Chrysikos, D, Bartsch, R. Platinum derivatives during pregnancy in cervical cancer: a systematic review and meta-analysis. Obstet Gynecol 2013; 121: 337–43.Google Scholar
McIntyre-Seltman, K, Lesnock, JL. Cervical cancer screening in pregnancy. Obstet Gynecol Clin North Am 2008; 35: 645–58; x.Google Scholar
Michael, CW, Esfahani, FM. Pregnancy-related changes: a retrospective review of 278 cervical smears. Diagn Cytopathol 1997; 17: 99–107.Google Scholar
Morimura, Y, Fujimori, K, Soeda, S, et al. Cervical cytology during pregnancy: comparison with non-pregnant women and management of pregnant women with abnormal cytology. Fukushima J Med Sci 2002; 48: 27–37.Google Scholar
Pisharodi, LR, Jovanoska, S. Spectrum of cytologic changes in pregnancy. A review of 100 abnormal cervicovaginal smears, with emphasis on diagnostic pitfalls. Acta Cytol 1995; 39: 905–8.Google Scholar
Rhatigan, RM. Endocervical gland atypia secondary to Arias-Stella change. Arch Pathol Lab Med 1992; 116: 943–6.Google Scholar
Schneider, V. Arias-Stella reaction of the endocervix: frequency and location. Acta Cytol 1981; 25: 224–8.Google Scholar
Jones, WB, Shingleton, HM, Russell, A, et al. Cervical carcinoma and pregnancy. A national patterns of care study of the American College of Surgeons. Cancer 1996; 77: 1479–88.Google Scholar
Baloglu, A, Uysal, D, Aslan, N, Yigit, S. Advanced stage of cervical carcinoma undiagnosed during antenatal period in term pregnancy and concomitant metastasis on episiotomy scar during delivery: a case report and review of the literature. Int J Gynecol Cancer 2007; 17: 1155–9.CrossRefGoogle ScholarPubMed
Van Calsteren, K, Vergote, I, Amant, F. Cervical neoplasia during pregnancy: diagnosis, management and prognosis. Best Pract Res Clin Obstet Gynaecol 2005; 19: 611–30.Google Scholar
Yang, KY. Abnormal pap smear and cervical cancer in pregnancy. Clin Obstet Gynecol 2012; 55: 838–48.Google Scholar
American College of Obstetricians and Gynecologists. Practice Bulletin No. 140: management of abnormal cervical cancer screening test results and cervical cancer precursors. Obstet Gynecol 2013; 122: 1338–67.Google Scholar
Karam, A, Feldman, N, Holschneider, CH. Neoadjuvant cisplatin and radical cesarean hysterectomy for cervical cancer in pregnancy. Nat Clin Pract Oncol 2007; 4: 375–80.Google Scholar
Lee, JM, Lee, KB, Kim, YT, et al. Cervical cancer associated with pregnancy: results of a multicenter retrospective Korean study (KGOG-1006). Am J Obstet Gynecol 2008; 198: 92.e1–6.CrossRefGoogle ScholarPubMed
Monk, BJ, Montz, FJ. Invasive cervical cancer complicating intrauterine pregnancy: treatment with radical hysterectomy. Obstet Gynecol 1992; 80: 199–203.Google Scholar
Sood, AK, Sorosky, JI, Krogman, S, et al. Surgical management of cervical cancer complicating pregnancy: a case–control study. Gynecol Oncol 1996; 63: 294–8.Google Scholar
van der Vange, N, Weverling, GJ, Ketting, BW, et al. The prognosis of cervical cancer associated with pregnancy: a matched cohort study. Obstet Gynecol 1995; 85: 1022–6.Google Scholar
Sood, AK, Sorosky, JI, Mayr, N, et al. Cervical cancer diagnosed shortly after pregnancy: prognostic variables and delivery routes. Obstet Gynecol 2000; 95: 832–8.Google Scholar
Cliby, WA, Dodson, MK, Podratz, KC. Cervical cancer complicated by pregnancy: episiotomy site recurrences following vaginal delivery. Obstet Gynecol 1994; 84: 179–82.Google Scholar
Copeland, LJ, Saul, PB, Sneige, N. Cervical adenocarcinoma: tumor implantation in the episiotomy sites of two patients. Gynecol Oncol 1987; 28: 230–5.Google Scholar
Gordon, AN, Jensen, R, Jones, HW. Squamous carcinoma of the cervix complicating pregnancy: recurrence in episiotomy after vaginal delivery. Obstet Gynecol 1989; 73: 850–2.Google Scholar
Schmeler, KM, Mayo-Smith, WW, Peipert, JF, et al. Adnexal masses in pregnancy: surgery compared with observation. Obstet Gynecol 2005; 105: 1098–103.Google Scholar
Whitecar, MP, Turner, S, Higby, MK. Adnexal masses in pregnancy: a review of 130 cases undergoing surgical management. Am J Obstet Gynecol 1999; 181: 19–24.Google Scholar
Moore, RD, Smith, WG. Laparoscopic management of adnexal masses in pregnant women. J Reprod Med 1999; 44: 97–100.Google Scholar
Bernhard, LM, Klebba, PK, Gray, DL, Mutch, DG. Predictors of persistence of adnexal masses in pregnancy. Obstet Gynecol 1999; 93: 585–9.Google Scholar
Zanetta, G, Mariani, E, Lissoni, A, et al. A prospective study of the role of ultrasound in the management of adnexal masses in pregnancy. BJOG. 2003; 110: 578–83.Google Scholar
Katz, VL, Watson, WJ, Hansen, WF, Washington, JL. Massive ovarian tumor complicating pregnancy: a case report. J Reprod Med 1993; 38: 907–10.Google Scholar
King, LA, Nevin, PC, Williams, PP, Carson, LF. Treatment of advanced epithelial ovarian carcinoma in pregnancy with cisplatin-based chemotherapy. Gynecol Oncol 1991; 41: 78–80.Google Scholar
American College of Obstetricians and Gynecologists. ACOG Practice Bulletin. Management of adnexal masses. Obstet Gynecol 2007; 110: 201–14.Google Scholar
Giuntoli, RL, Vang, RS, Bristow, RE. Evaluation and management of adnexal masses during pregnancy. Clin Obstet Gynecol 2006; 49: 492–505.CrossRefGoogle ScholarPubMed
Eichelberger, KY, Cantrell, LA, Balthazar, U, et al. Robotic resection of adnexal masses during pregnancy. Am J Perinatol 2013; 30: 371–5.Google Scholar
Christman, JE, Teng, NN, Lebovic, GS, Sikic, BI. Delivery of a normal infant following cisplatin, vinblastine, and bleomycin (PVB) chemotherapy for malignant teratoma of the ovary during pregnancy. Gynecol Oncol 1990; 37: 292–5.Google Scholar
Han, JY, Nava-Ocampo, AA, Kim, TJ, Shim, JU, Park, CT. Pregnancy outcome after prenatal exposure to bleomycin, etoposide and cisplatin for malignant ovarian germ cell tumors: report of 2 cases. Reprod Toxicol 2005; 19: 557–61.Google Scholar
Malone, JM, Gershenson, DM, Creasy, RK, et al. Endodermal sinus tumor of the ovary associated with pregnancy. Obstet Gynecol 1986; 68 (3 Suppl): 86S–89S.Google Scholar
Blake, EA, Kodama, M, Yunokawa, M, et al. Feto-maternal outcomes of pregnancy complicated by epithelial ovarian cancer: a systematic review of literature. Eur J Obstet Gynecol Reprod Biol 2015; 186C: 97–105.Google Scholar
Grimm, D, Woelber, L, Trillsch, F, Keller-v Amsberg, G, Mahner, S. Clinical management of epithelial ovarian cancer during pregnancy. Eur J Cancer 2014; 50: 963–71.CrossRefGoogle ScholarPubMed
Regan, MA, Rosenzweig, BA. Vulvar carcinoma in pregnancy: a case report and literature review. Am J Perinatol 1993; 10: 334–5.Google Scholar
Maw, RD. Treatment of external genital warts with 5% imiquimod cream during pregnancy: a case report. BJOG 2004; 111: 1475.Google Scholar
Nelson, EL, Stockdale, CK. Vulvar and vaginal HPV disease. Obstet Gynecol Clin North Am 2013; 40: 359–76.Google Scholar
Carinelli, SG, Cefis, F, Merlo, D. Epithelial neoplasia of the endometrium in pregnancy. A case report. Tumori 1987; 73: 175–80.Google Scholar
Fine, BA, Baker, TR, Hempling, RE, Intengan, M. Pregnancy coexisting with serous papillary adenocarcinoma involving both uterus and ovary. Gynecol Oncol 1994; 53: 369–72.Google Scholar
Ojomo, EO, Ezimokhai, M, Reale, FR, Nwabineli, NJ. Recurrent postpartum haemorrhage caused by endometrial carcinoma co-existing with endometrioid carcinoma of the ovary in a full term pregnancy. Br J Obstet Gynaecol 1993; 100: 489–91.Google Scholar
Vaccarello, L, Apte, SM, Copeland, LJ, Boutselis, JG, Rubin, SC. Endometrial carcinoma associated with pregnancy: a report of three cases and review of the literature. Gynecol Oncol 1999; 74: 118–22.Google Scholar
Antonelli, NM, Dotters, DJ, Katz, VL, Kuller, JA. Cancer in pregnancy: a review of the literature. Part II. Obstet Gynecol Surv 1996; 51: 135–42.Google Scholar
Antonelli, NM, Dotters, DJ, Katz, VL, Kuller, JA. Cancer in pregnancy: a review of the literature. Part I. Obstet Gynecol Surv 1996; 51: 125–34.Google Scholar
Sebire, NJ, Jauniaux, E. Fetal and placental malignancies: prenatal diagnosis and management. Ultrasound Obstet Gynecol 2009; 33: 235–44.Google Scholar
Altman, JF, Lowe, L, Redman, B, et al. Placental metastasis of maternal melanoma. J Am Acad Dermatol 2003; 49: 1150–4.Google Scholar
Dessolle, L, Dalmon, C, Roche, B, Darai, E. [Placental metastases from maternal malignancies: review of the literature]. J Gynecol Obstet Biol Reprod (Paris) 2007; 36: 344–53.Google Scholar
Eltorky, M, Khare, VK, Osborne, P, Shanklin, DR. Placental metastasis from maternal carcinoma: a report of three cases. J Reprod Med 1995; 40: 399–403.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×